Regencell Bioscience Holdings Stock Probability of Future Stock Price Finishing Over 5.65
| RGC Stock | USD 5.65 0.05 0.88% |
Regencell |
Regencell Bioscience Target Price Odds to finish over 5.65
The tendency of Regencell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.65 | 90 days | 5.65 | about 70.44 |
Based on a normal probability distribution, the odds of Regencell Bioscience to move above the current price in 90 days from now is about 70.44 (This Regencell Bioscience Holdings probability density function shows the probability of Regencell Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Regencell Bioscience Holdings has a beta of -1.12 indicating Additionally Regencell Bioscience Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Regencell Bioscience Price Density |
| Price |
Predictive Modules for Regencell Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Regencell Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Regencell Bioscience Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Regencell Bioscience is not an exception. The market had few large corrections towards the Regencell Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Regencell Bioscience Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Regencell Bioscience within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | -1.12 | |
σ | Overall volatility | 1.08 | |
Ir | Information ratio | -0.02 |
Regencell Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Regencell Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Regencell Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Regencell Bioscience generated a negative expected return over the last 90 days | |
| Regencell Bioscience has high historical volatility and very poor performance | |
| Reported Net Loss for the year was (4.36 M) with profit before taxes, overhead, and interest of 0. | |
| Regencell Bioscience Holdings has about 59.41 K in cash with (4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 89.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Segall Bryant Hamill LLC Sells 44,983 Shares of Regal Rexnord Co. |
Regencell Bioscience Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Regencell Stock often depends not only on the future outlook of the current and potential Regencell Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regencell Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13 M | |
| Cash And Short Term Investments | 8 M |
Regencell Bioscience Technical Analysis
Regencell Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. Regencell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regencell Bioscience Holdings. In general, you should focus on analyzing Regencell Stock price patterns and their correlations with different microeconomic environments and drivers.
Regencell Bioscience Predictive Forecast Models
Regencell Bioscience's time-series forecasting models is one of many Regencell Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Regencell Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Regencell Bioscience
Checking the ongoing alerts about Regencell Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Regencell Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Regencell Bioscience generated a negative expected return over the last 90 days | |
| Regencell Bioscience has high historical volatility and very poor performance | |
| Reported Net Loss for the year was (4.36 M) with profit before taxes, overhead, and interest of 0. | |
| Regencell Bioscience Holdings has about 59.41 K in cash with (4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 89.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Segall Bryant Hamill LLC Sells 44,983 Shares of Regal Rexnord Co. |
Check out Regencell Bioscience Backtesting, Regencell Bioscience Valuation, Regencell Bioscience Correlation, Regencell Bioscience Hype Analysis, Regencell Bioscience Volatility, Regencell Bioscience History as well as Regencell Bioscience Performance. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.33) | Return On Assets (0.28) | Return On Equity (0.43) |
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.